Pharming Group revenue and financials
In the fiscal year ended December 2025, Pharming Group reported revenue of $376.13M (+26.56% year over year). Net income was $2.85M, a net margin of 0.8%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +26.56%
- 2025 vs 2024
- Net margin
- 0.8%
- 2024: -4.0%
How Pharming Group is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 12.1% a year on average over the last 5 years
Compound annual growth rate: from $212.17M in 2020 to $376.13M in 2025.
Revenue has grown for 4 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 5.0% to 8.7%
Operating income over revenue, 2022 → 2025: 3.7 percentage points.
Shares outstanding up 9.4% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 3 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 376 | 297 | 245 | 206 | 199 | 212 | 189 | 155 | 108 | 16.7 |
| Cost of revenue | 45.5 | 35.4 | 25.2 | 17.6 | 21.1 | 23.5 | 23.9 | 25.4 | 14.9 | 4.9 |
| Gross profit | 331 | 262 | 220 | 188 | 178 | 189 | 165 | 130 | 92.6 | 11.8 |
| Selling, general and administrative | 202 | 184 | 175 | 127 | 91.0 | 75.7 | 65.9 | 53.6 | 44.9 | 8.1 |
| Research and development | 98.2 | 83.1 | 68.7 | 52.5 | 65.4 | 38.5 | 32.6 | 33.1 | 22.4 | 16.2 |
| Operating income | 32.8 | -3.6 | -21.8 | 10.4 | 24.0 | 76.3 | 67.4 | 43.6 | 26.3 | -12.1 |
| EBIT | 32.8 | -3.6 | -21.8 | 10.4 | 24.0 | 76.3 | 67.4 | 43.6 | 26.3 | -12.1 |
| EBITDA | 39.6 | 3.2 | -15.3 | 17.1 | 30.4 | 82.5 | 72.4 | 48.0 | 30.3 | -11.4 |
| Interest expense | 10.7 | 8.7 | 6.0 | 5.4 | 6.1 | 5.9 | 13.4 | 16.4 | 22.4 | 3.8 |
| Pre-tax income | 12.8 | -8.5 | -12.0 | 15.0 | 23.1 | 44.1 | 52.3 | 1.0 | -103 | -18.4 |
| Income tax | 10.3 | 3.3 | -1.5 | 1.3 | 7.1 | 6.3 | 11.7 | -27.7 | -11.3 | — |
| Net income | 2.9 | -11.8 | -10.5 | 13.7 | 16.0 | 37.7 | 40.6 | 28.7 | -91.5 | -18.4 |
| Net income to common shareholders | 2.9 | -11.8 | -10.5 | 13.7 | 16.0 | 37.7 | 40.6 | 28.7 | -91.5 | -18.4 |
| Basic EPS | 0.00 | -0.02 | -0.02 | 0.02 | 0.02 | 0.06 | 0.06 | 0.05 | -0.18 | -0.04 |
| Diluted EPS | 0.00 | -0.02 | -0.02 | 0.02 | 0.02 | 0.05 | 0.06 | 0.04 | -0.18 | -0.04 |
| Average shares (basic) | 689 | 671 | 657 | 649 | 642 | 636 | 626 | 607 | 500 | 415 |
| Average shares (diluted) | 747 | 671 | 657 | 707 | 701 | 683 | 674 | 654 | 500 | 415 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 90.2 | 72.4 | 107 | 97.3 | 93.2 | 79.1 | 92.7 | 74.8 | 74.1 | 55.6 | 81.2 | 66.7 |
| Cost of revenue | 14.5 | 6.6 | 21.1 | 7.1 | 9.0 | 8.3 | 12.2 | 6.8 | 8.0 | 8.4 | 7.1 | 8.3 |
| Gross profit | 75.7 | 65.8 | 85.4 | 90.2 | 84.2 | 70.8 | 80.5 | 68.0 | 66.1 | 47.2 | 74.1 | 58.4 |
| Selling, general and administrative | 43.5 | 45.5 | 50.7 | 43.1 | 51.6 | 57.1 | 46.6 | 44.0 | 48.5 | 45.3 | 57.3 | 36.0 |
| Research and development | 32.3 | 25.6 | 32.0 | 21.3 | 23.7 | 21.1 | 22.3 | 20.7 | 21.6 | 18.5 | 11.4 | 20.8 |
| Operating income | 1.3 | -4.9 | 3.0 | 25.9 | 10.8 | -7.0 | 11.7 | 4.1 | -3.1 | -16.3 | -15.3 | 1.9 |
| EBIT | 1.3 | -4.9 | 3.0 | 25.9 | 10.8 | -7.0 | 11.7 | 4.1 | -3.1 | -16.3 | -15.3 | 1.9 |
| EBITDA | 2.7 | -1.8 | 6.2 | 30.1 | 12.1 | -4.5 | 19.4 | 6.9 | -1.2 | -10.4 | -7.7 | 6.6 |
| Interest expense | 4.1 | 2.7 | 1.4 | 9.2 | 0.0 | 5.1 | 1.2 | 3.0 | 2.0 | 1.6 | 1.3 | — |
| Pre-tax income | 3.0 | -4.8 | 4.8 | 12.8 | 7.1 | -11.8 | 6.7 | 1.5 | -0.1 | -16.6 | -2.0 | 3.3 |
| Income tax | 1.4 | 0.5 | -0.5 | 5.2 | 2.5 | 3.1 | 3.8 | 2.5 | 1.2 | -4.2 | 1.1 | -0.2 |
| Net income | 1.6 | -5.2 | 5.3 | 7.5 | 4.7 | -14.7 | 2.9 | -1.0 | -1.2 | -12.4 | -3.1 | 3.5 |
| Net income to common shareholders | 1.6 | -5.2 | 5.3 | 7.5 | 4.7 | -14.7 | 2.9 | -1.0 | -1.2 | -12.4 | -3.1 | 3.5 |
| Basic EPS | 0.00 | -0.01 | 0.01 | 0.02 | 0.01 | -0.02 | 0.00 | -0.00 | -0.00 | -0.02 | -0.00 | 0.01 |
| Diluted EPS | 0.00 | -0.01 | 0.01 | 0.02 | 0.01 | -0.02 | 0.00 | -0.00 | -0.00 | -0.02 | -0.00 | 0.01 |
| Average shares (basic) | 666 | 745 | 663 | 502 | 686 | 669 | 740 | 517 | 689 | 655 | 675 | 700 |
| Average shares (diluted) | 666 | 745 | 757 | 502 | 686 | 669 | 740 | 517 | 689 | 655 | 675 | 700 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 500 | 400 | 463 | 426 | 397 | 418 | 256 | 246 | 199 | 133 |
| Current assets | 299 | 278 | 316 | 278 | 249 | 263 | 119 | 132 | 106 | 65.4 |
| Cash and equivalents | 145 | 54.9 | 61.7 | 207 | 192 | 205 | 74.3 | 92.1 | 70.4 | 33.5 |
| Short-term investments | 33.8 | 113 | 152 | 0.0 | — | — | — | — | — | — |
| Receivables | 48.4 | 50.2 | 42.6 | 25.3 | 27.6 | 31.9 | 28.9 | 18.4 | 12.2 | 12.0 |
| Inventory | 64.9 | 55.7 | 56.8 | 42.3 | 27.3 | 21.2 | 16.2 | 19.9 | 22.0 | 18.9 |
| Net property, plant and equipment | 24.0 | 24.1 | 33.5 | 39.1 | 33.2 | 21.7 | 16.3 | 9.6 | 9.9 | 6.4 |
| Goodwill | 3.3 | 0.0 | — | — | — | — | — | — | — | — |
| Other intangible assets | 132 | 61.0 | 71.3 | 74.9 | 83.6 | 88.6 | 74.6 | 57.6 | 63.6 | 58.8 |
| Long-term investments | 8.6 | 4.2 | 10.4 | 9.7 | 8.7 | 7.1 | 6.2 | — | — | — |
| Current liabilities | 116 | 73.8 | 78.0 | 59.7 | 46.8 | 76.8 | 114 | 94.7 | 72.9 | 54.0 |
| Accounts payable | 8.5 | 10.1 | 16.0 | 8.8 | 7.6 | 13.5 | 40.6 | 7.6 | 11.3 | 5.9 |
| Long-term debt | 92.7 | 78.2 | 137 | 132 | 139 | 150 | — | 42.7 | 71.0 | 42.5 |
| Total debt | 116 | 112 | 172 | 167 | 162 | 162 | 58.2 | 83.6 | 98.6 | 70.9 |
| Total liabilities | 223 | 179 | 244 | 221 | 204 | 235 | 139 | 175 | 180 | 104 |
| Total equity (incl. minority) | 277 | 221 | 219 | 205 | 193 | 183 | 117 | 70.8 | 19.3 | 28.9 |
| Retained earnings | -258 | -288 | -265 | -265 | -270 | -271 | -332 | -381 | -424 | -293 |
| Minority interest | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 468 | 489 | 500 | 474 | 446 | 403 | 400 | 426 | 416 | 442 | 463 | 436 |
| Current assets | 281 | 296 | 299 | 278 | 246 | 214 | 278 | 282 | 271 | 297 | 316 | 292 |
| Cash and equivalents | 158 | 52.4 | 145 | 132 | 92.1 | 60.1 | 54.9 | 60.7 | 47.1 | 51.9 | 61.7 | 54.7 |
| Short-term investments | 0.0 | 118 | 33.8 | 33.8 | 33.9 | 47.2 | 113 | 111 | 113 | 150 | 152 | 143 |
| Receivables | 57.0 | 60.0 | 48.4 | 43.6 | 53.3 | 47.5 | 50.2 | 48.2 | 51.1 | 38.7 | 42.6 | 40.5 |
| Inventory | 65.4 | 64.6 | 64.9 | 67.1 | 63.7 | 59.3 | 55.7 | 62.2 | 59.2 | 55.9 | 56.8 | 53.4 |
| Net property, plant and equipment | 20.5 | 23.1 | 24.0 | 25.0 | 24.6 | 24.2 | 24.1 | 30.7 | 30.7 | 31.9 | 33.5 | 37.5 |
| Goodwill | — | — | 3.3 | — | — | — | — | — | — | — | — | — |
| Other intangible assets | 128 | 131 | 132 | 135 | 136 | 139 | 61.0 | 67.1 | 66.6 | 68.3 | 71.3 | 69.8 |
| Long-term investments | 8.6 | 8.1 | 8.6 | 6.7 | 6.7 | 5.9 | 4.2 | 7.2 | 7.4 | 7.7 | 10.4 | 9.2 |
| Current liabilities | 93.2 | 112 | 116 | 87.9 | 87.9 | 77.5 | 73.8 | 79.8 | 79.9 | 207 | 78.0 | 68.1 |
| Accounts payable | 82.3 | 104 | 8.5 | 78.2 | 78.4 | 68.7 | 10.1 | 72.6 | 73.0 | 68.5 | 16.0 | 62.5 |
| Long-term debt | 92.4 | 93.4 | 92.7 | 93.1 | 91.3 | 83.8 | 78.2 | 92.1 | 87.3 | — | 137 | 130 |
| Total debt | 113 | 116 | 116 | 131 | 128 | 119 | 112 | 127 | 122 | 167 | — | — |
| Total liabilities | 197 | 220 | 223 | 209 | 207 | 188 | 179 | 200 | 195 | 236 | 244 | 227 |
| Total equity (incl. minority) | 270 | 269 | 277 | 265 | 240 | 215 | 221 | 226 | 221 | 206 | 219 | 210 |
| Retained earnings | -271 | -281 | -258 | -277 | -286 | -284 | -288 | -269 | -274 | -281 | -265 | -274 |
| Minority interest | 0.0 | 0.0 | 0.0 | — | — | 1.3 | — | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 54.7 | -1.8 | -17.3 | 22.5 | 37.8 | 83.6 | 74.1 | 46.3 | 45.8 | -10.5 |
| Depreciation and amortization | 10.3 | 10.2 | 10.1 | 9.3 | 9.2 | 8.3 | 6.6 | 4.5 | 4.0 | 0.7 |
| Capital expenditure | -0.7 | -0.8 | -1.4 | -1.4 | -10.7 | -4.7 | -2.6 | -2.9 | -3.9 | -1.3 |
| Investing cash flow | 26.3 | 31.6 | -129 | 5.3 | -21.3 | -15.6 | -28.3 | -4.3 | -7.3 | -60.4 |
| Financing cash flow | 1.5 | -34.4 | -1.0 | -5.0 | -27.9 | 60.7 | -63.5 | -20.6 | -3.9 | 70.8 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Debt issued | 0.0 | 105 | 0.0 | 0.0 | — | 143 | — | — | 110 | 72.0 |
| Debt repaid | -4.2 | -139 | -4.0 | -3.3 | -3.2 | -59.4 | -37.4 | -19.9 | -108 | -1.8 |
| Effect of exchange rates | 7.9 | -2.2 | 2.1 | -7.4 | -1.8 | 2.1 | 0.1 | 3.3 | -1.3 | 0.5 |
| Net change in cash | 90.4 | -6.8 | -146 | 15.4 | -13.2 | 131 | -17.5 | 24.7 | 33.4 | 0.3 |
| Free cash flow | 54.0 | -2.6 | -18.7 | 21.1 | 27.1 | — | — | — | — | — |
| Levered free cash flow | 68.7 | 0.2 | 8.1 | 16.2 | -17.1 | 44.3 | 22.4 | 25.6 | 19.1 | -4.2 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -9.7 | 2.0 | 10.7 | 32.0 | 11.7 | 0.2 | 9.3 | 9.7 | -13.2 | -7.6 | 11.6 | 3.5 |
| Depreciation and amortization | 2.9 | 3.1 | 2.3 | 2.7 | 2.7 | 2.6 | 1.8 | 2.7 | -0.3 | 5.9 | 1.8 | 2.9 |
| Capital expenditure | -0.1 | -0.2 | -0.3 | -0.1 | -0.1 | -0.3 | -0.1 | -0.4 | -0.2 | -0.1 | -0.3 | -0.1 |
| Investing cash flow | -0.1 | -84.8 | -0.0 | -0.3 | 17.0 | 9.7 | -9.8 | 4.4 | 36.4 | 0.7 | -3.9 | -146 |
| Financing cash flow | -2.4 | -9.2 | 1.0 | 9.9 | -2.8 | -6.7 | -2.2 | -1.4 | -28.3 | -2.5 | -1.0 | 5.2 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Debt issued | — | — | 0.0 | — | — | — | 0.0 | — | 105 | — | — | — |
| Debt repaid | -0.9 | -13.0 | -1.4 | -1.1 | -1.1 | -0.7 | -1.5 | -1.2 | -135 | -1.3 | -0.2 | -1.3 |
| Effect of exchange rates | 0.3 | -0.9 | 1.2 | -1.3 | 6.1 | 1.9 | -3.1 | 0.9 | 0.4 | -0.4 | 0.4 | -0.9 |
| Net change in cash | 106 | -92.9 | 12.9 | 40.3 | 32.0 | 5.1 | -5.7 | 13.5 | -4.8 | -9.8 | 7.1 | -138 |
| Free cash flow | -9.7 | 1.7 | 10.4 | 32.0 | 11.6 | -0.1 | 9.2 | 9.4 | -13.4 | -7.7 | 11.3 | 3.4 |
| Levered free cash flow | -12.7 | -6.5 | 29.3 | 24.5 | 9.5 | 3.1 | 5.6 | 5.5 | -11.7 | 1.4 | -3.4 | -0.8 |
Financial statements of similar companies
Companies in the group: same industry, similar size
